ICON
Shiloh Whitehead has a diverse range of work experience in the field of clinical trials and project management. Shiloh started their career at INC Research in 2000, where they worked as an Assoc. Manager in Regulatory Review & Records Management and as a Clinical Research Associate. In this role, they established and managed centralized document repository rooms for CRFs and essential documents.
In 2002, Shiloh joined PRA International and held various positions including Project Director, Molecule Manager, Project Manager, and Lead CRA. During their time at PRA International, they gained extensive experience in project management and leadership.
In 2012, Shiloh moved to PAREXEL and was appointed as the Portfolio Director for Primary Care. In this role, they provided oversight for Primary Care clinical trials across multiple countries and assets, managing a large global team and ensuring the successful operational delivery of services.
Currently, Shiloh is working at ICON plc, starting in 2014. Shiloh initially served as the Group Sr. Director of Project Management for Oncology & Hematology, responsible for the leadership of Project Managers and Directors. Currently, they hold the position of Vice President in Strategic Alliance Management, where they oversee the management of strategic partnerships, ensuring compliance with SOPs, contracts, and budgets.
Overall, Shiloh Whitehead's work experience highlights their expertise in project management, leadership, and strategic alliance management within the clinical trial industry.
Shiloh Whitehead has a Bachelor of Arts (B.A.) degree in Biology from Randolph College. Additionally, they hold a Master of Science (M.S.) degree in Health Sciences - Clinical Research Administration from The George Washington University School of Medicine and Health Sciences. Shiloh Whitehead has also obtained certifications as a Court Appointed Special Advocate (CASA) in 2003 and as a Regulatory Affairs Certified individual in 2002.
This person is not in any offices
ICON
41 followers
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries.